Bottom line
How much do PJP and GGHCX overlap?
36% of their top holdings overlap by weight. 8 securities appear in both funds' top 25, making up 40.1% of PJP's assets and 37.2% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
GGHCX holds far more positions (82 vs 33), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PJP and GGHCX have in common
| Holding | % of PJP | % of GGHCX | Overlap |
|---|---|---|---|
| Invesco Private Prime Fund | 7.93% | 4.67% | 4.67% |
| AbbVie Inc. | 5.48% | 4.03% | 4.03% |
| Johnson & Johnson | 5.18% | 6.76% | 5.18% |
| Merck & Co., Inc. | 5.06% | 4.59% | 4.59% |
| Eli Lilly and Co. | 5.02% | 10.59% | 5.02% |
| Gilead Sciences, Inc. | 4.53% | 3.63% | 3.63% |
| Invesco Private Government Fund | 3.73% | 1.80% | 1.80% |
| Ligand Pharmaceuticals Inc. | 3.20% | 1.18% | 1.18% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PJP
- Abbott Laboratories — 5.67%
- Amgen Inc. — 5.33%
- Corcept Therapeutics Inc. — 4.96%
- Pfizer Inc. — 4.50%
- Amneal Pharmaceuticals, Inc. — 3.75%
- Liquidia Corp. — 3.66%
- Travere Therapeutics, Inc. — 3.30%
- Regeneron Pharmaceuticals, Inc. — 3.14%
- Harmony Biosciences Holdings, Inc. — 3.06%
- Bristol-Myers Squibb Co. — 2.94%
- Viatris Inc. — 2.83%
- Jazz Pharmaceuticals PLC — 2.79%
- Biogen Inc. — 2.75%
- Collegium Pharmaceutical, Inc. — 2.74%
- Prestige Consumer Healthcare Inc. — 2.74%
Only in GGHCX
- UnitedHealth Group Inc. — 6.17%
- argenx SE — 3.24%
- CVS Health Corp. — 2.52%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Cardinal Health, Inc. — 2.10%
- Guardant Health, Inc. — 2.04%
- Vertex Pharmaceuticals Inc. — 2.01%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- Thermo Fisher Scientific Inc. — 1.55%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
Asset mix
| Asset type | PJP | GGHCX |
|---|---|---|
| Stocks | 99.9% | 97.5% |
| Cash & short-term funds | 11.8% | 8.8% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | PJP | GGHCX |
|---|---|---|
| US | 106.5% | 93.5% |
| IE | 5.2% | 0.6% |
| NL | — | 3.4% |
| GB | — | 3.1% |
| CH | — | 2.7% |
| BE | — | 1.2% |
| DK | — | 1.1% |
| IL | — | 0.4% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PJP and GGHCX overlap?
What stocks do PJP and GGHCX have in common?
Should I own both PJP and GGHCX?
Which holds more stocks, PJP or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.